
[Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2
CAS No. 213130-17-7
[Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2 ( —— )
产品货号. M30625 CAS No. 213130-17-7
Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | 获取报价 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称[Phe1Ψ(CH2-NH)Gly2]Nociceptin(1-13)NH2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).
-
产品描述Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number213130-17-7
-
分子量1367.6
-
分子式C61H102N22O14
-
纯度>98% (HPLC)
-
溶解度water:0.70 mg/mL
-
SMILES[H]N[C@H](CNCC(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(N)=O)CC1=CC=CC=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Guerrini et al (1997) Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin (1-13)-peptide amide. J.Med.Chem. 40 1789 PMID:
产品手册




关联产品
-
Gypenoside LI
Gypenoside LI possesses non-small cell lung carcinoma A549 cell inhibitory activity.
-
1-Undecanol
1-Undecanol 能够通过微生物氧化 2-tridecanol 而产生。
-
Hydroxyprogesterone ...
己酸羟孕酮是一种合成孕激素。它结合并激活生殖系统中的核黄体酮受体,抑制排卵以及宫颈粘液和子宫内膜的改变。